<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "aliskiren tab>
<dose><value>150</value>
<value>300</value>
</dose><route><value>PO</value>
</route><form><value>tab</value>
</form><drug><value>aliskiren tab</value>
</drug><strength><value>150 mg</value>
</strength><frequency><value>DAILY</value>
</frequency><instruction><value></value>
</instruction><volume><value></value>
</volume><units><value>mg</value>
</units><additionalnotes><value>Aliskiren or Aliskiren-containing fixed combination products contraindicated in diabetic patients receiving an ACE inhibitor or Angiotensin receptor blocker product: increased incidence of non-fatal strokes, renal complications, hyperkalemia and hypotension; ALTITUDE study. Health Canada Advisory, 2012Jan18.</value>
</additionalnotes><population><value></value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value></value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Non-Formulary.</value>
</ahsformularystatus><ahfsname><value>Renin-Angiotensin-Aldosterone System Inhibitors, Renin Inhibitors</value>
</ahfsname><highalert><value></value>
</highalert><maximumprndose><value></value>
</maximumprndose></drug>